Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Yaber and Pantone Color Institute Reunite: Introducing Yaber Projector L2s in Stunning Misty White and Lunar Rock
-
Ionis reports third quarter 2024 financial results
-
IsoEnergy Summer Drilling Intersects Multiple Areas of Radioactivity Highlighting the Prospectivity of the Larocque Trend
-
BitSmiley, a Bitcoin-native Stablecoin Protocol, Will Be Initially Listed on CoinW Exchange
-
Starwood Property Trust Reports Results for Quarter Ended September 30, 2024
-
Vishay Intertechnology to Acquire Birkelbach, Manufacturer of Metalized Technical Films
-
Secura Bio Announces Poster Presentation Highlighting New COPIKTRA® (duvelisib) Data for the Treatment of Patients With Peripheral T-Cell Lymphoma and Other Advanced Hematologic Malignancies at the 2
-
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
-
Dine Brands Global, Inc. Reports Third Quarter 2024 Results
-
Delek Logistics Reports Record Third Quarter 2024 Results
-
Howmet Aerospace Reports Third Quarter 2024 Results
-
Sunoco LP Reports Third Quarter 2024 Financial and Operating Results
-
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
-
Flare Therapeutics to Present at Two Upcoming November Conferences
-
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024
-
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Argentina Lithium Applies to Extend Warrants
-
Stay Connected with Satellite Phone Store as Hurricane Rafael Approaches
-
HAMILTON LANE INCORPORATED REPORTS SECOND QUARTER FISCAL 2025 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 10% AND ASSETS UNDER MANAGEMENT GROWING BY 10% YEAR-OVER-YEAR
-
XpertDox Partners with Lone Star Circle of Care to Optimize Medical Coding Using AI
-
American Shared Hospital Services Announces Third Quarter 2024 Earnings Conference Call
-
Angel Oak Mortgage REIT, Inc. Reports Third Quarter 2024 Financial Results
-
Charles River Laboratories Announces Third-Quarter 2024 Results
-
FEETURES CELEBRATES GRAND OPENING OF NEW DISTRIBUTION CENTER WITH RIBBON CUTTING CEREMONY
-
Transposon to Present Results from Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related ALS/FTD at the 7th Annual ALS ONE Research Symposium
-
Insulin Delivery Innovator PharmaSens Appoints Robert Gabbay, MD and James Peterson to Board of Directors
-
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
-
EchoStar Corporation Announces Conference Call for Third Quarter 2024 Financial Results
-
Valona introduces cutting-edge foresight tools for global enterprises
-
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
-
Unwrap the Joy: Pinspark Fulfills Your Black Friday's Wishlist
-
D-Wave Achieves Significant Milestone with Calibration of 4,400+ Qubit Advantage2 Processor
-
Regis Corporation Reports Continued Profitability for the First Fiscal Quarter 2025
-
VSE Corporation Announces Third Quarter 2024 Results
-
Performance Food Group Company Reports First-Quarter Fiscal 2025 Results
-
Zevia Announces Third Quarter 2024 Results
-
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
-
Cellebrite Announces Third-Quarter 2024 Results
-
Laser Photonics Completes Acquisition of Control Micro Systems - Expands Into Pharmaceutical Laser Equipment Market
-
BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s Annual Meeting
-
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
-
YHN Acquisition I Limited Announces the Separate Trading of its Ordinary Shares and Rights, Commencing November 8, 2024
-
WW International, Inc. Announces Third Quarter 2024 Results
-
Macerich Reports Third Quarter 2024 Results
-
Stella-Jones Announces Third Quarter Results and Updates 2023-2025 Financial Objectives
-
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
-
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
-
LENZ Therapeutics Reports Third Quarter 2024 Financial Results
-
The ODP Corporation Embarks on a New 10-Year, $1.5B Transformative Partnership with Nationally Recognized Strategic Reseller
-
ScottsMiracle-Gro Reports Fiscal 2024 Fourth Quarter and Full-Year Results

